Impact of Nano-Selenium supplementation on the JAK/STAT signaling pathway in major depressive disorder: a Triple-Blind, randomized controlled trial
The research received approval from the Research Ethics Committees of Iran University of Medical Sciences (Approval ID: IR IUMS.REC.1402.206, dated 2023-06-13) and was duly registered with the Iranian Registry of Clinical Trials (IRCT; registration number: IRCT20091114002709N62, dated 2023-07-29).
Authors
- Ali Amini (ORCID: https://orcid.org/0000-0002-8759-6120)
- Farnaz Etesam (ORCID: https://orcid.org/0000-0002-4083-4216)
- Morvarid Noormohammadi (ORCID: https://orcid.org/0000-0002-1971-8982)
- Farzad Shidfar (ORCID: https://orcid.org/0000-0002-6531-9253)
- Morteza Mohammadzadeh (ORCID: https://orcid.org/0000-0002-2258-3388)
- Pegah Khosravian (ORCID: https://orcid.org/0000-0002-4802-8534)
Institutions
- Iran University of Medical Sciences (IR)
- Shahrekord University of Medical Sciences (IR)
- Imam Khomeini Hospital (IR)
Publication Details
- Journal
- BMC Psychiatry
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1186/s12888-025-07213-4
- Citations
- 2
- Primary Topic
- Selenium in Biological Systems
- Type
- article
- Field-Weighted Citation Impact
- 2.24
Funders
- Iran University of Medical Sciences